Feature | N.(n = 100) | SAA [mg/L, M (QR)] | Z | P |
---|---|---|---|---|
Age(y) | ||||
≥ 60 | 55 (55%) | 51.7 (15.63,187.95) | 1.254 | 0.516 |
< 60 | 45 (45%) | 57.6 (18.35,180.7) | ||
FIGO stage | ||||
I-II | 30 (30%) | 8.8 (6.30,32. 3) | 7.106 | 0.003 |
III | 25 (25%) | 42.1 (12.8166.35) | ||
IV | 45 (45%) | 68.30 (22.63,187.95) | ||
Histology subtype | ||||
Serous | 64 (64%) | 8.8 (6.4,79.8) | −3.017 | 0.002 |
Endometrioid | 36 (36%) | 55.8 (22.85,192.65) | ||
Lymphatic invasion | ||||
No | 41 (41%) | 17.7 (7.42,43.47) | −3.927 | 0.000 |
Yes | 59 (59%) | 157.4 (66.43,216.6) | ||
Distant metastasis | ||||
NO | 55 (55%) | 13.60 (6.15,46.23) | −3.416 | 0.001 |
Yes | 45 (45%) | 80.90 (29.23,211.03) | ||
ER | ||||
Positive | 70 (70%) | 27.90 (8.20,156.30) | 0.810 | 0.418 |
Negative | 30 (30%) | 17.40 (6.90,108.40) | ||
PR | ||||
Positive | 39 (39%) | 32.30 (6.85,136.60) | 0.265 | 0.791 |
Negative | 61 (61%) | 27.30 (7.70,136.00) |